Korean J Transplant.  2020 Dec;34(Supple 1):S41. 10.4285/ATW2020.OP-1211.

Introducing robot-assisted laparoscopic donor nephrectomy after experience in retroperitoneal endoscopic living donor nephrectomy approach

Affiliations
  • 1Department of Urology, Cho Ray Hospital, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
  • 2Department of Urology, Cho Ray Hospital, Ho Chi Minh City, Vietnam
  • 3Department of Urology, National University Hospital, Singapore

Abstract

Background
This study aims to assess safety and efficacy of introducing robot-assisted laparoscopic donor nephrectomy (RALDN) to the standard retroperitoneal endoscopic living donor nephrectomy (RELDN) at a single institution transplant program.
Methods
Data were collected prospectively from 68 consecutive living kidney donors (14 for RALDN subgroup and 54 RELDN subgroup) at a transplant center from February 2018 to September 2019. Patient baseline demographics, radiological findings, perioperative donor outcomes, recipient outcomes, and complications were recorded, and these parameters were compared between the two surgical groups.
Results
For the entire group, mean age±standard deviation was 51.4±8.9 years (range, 29–68 years); 44.1% were males; mean body mass index (BMI) was 22.6±2.3 kg/㎡(range, 15.6–27.3 kg/㎡ ); and there were 57 (84%) left kidneys. Preoperatively, there was no significant differences (P>0.05) between the two donor groups including gender, BMI, kidney side, hilar anatomy, and American Society of Anesthesiologists status. For perioperative outcomes, there was no significant differences (P>0.05) comparing RALDN and RELDN respectively for warm ischemic time (4.7±1.4 minutes vs. 4.8±1.4 minutes), operative time (232±43 minutes vs. 217±41 minutes), hemoglobin drop (7.5±5.8 g/L vs. 8.5±7.2 g/L), postoperative complications (7.1% vs. 7.4%), the donor blood creatinine at 1 month (1.13±0.22 mg/dL vs. 1.22±0.26 mg/dL), and the recipient blood creatinine at 1 month (1.25±0.28 mg/dL vs. 1.41±0.38 mg/dL).
Conclusions
This study showed that RALDN can be safely introduced into living donor program experienced in laparoscopic donor nephrectomy.

Full Text Links
  • KJT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr